-
Beckman Coulter; Thomas Jefferson University; Laboraf Diagnostica e Ricerca San Raffaele SpA; BioSphere Medical; DuPont Applied BioSciences; GE Healthcare; Draximage; Draxis Health; HemCon Medical Technologies; AutoMedx; Toshiba Medical Systems; TomTec Imaging Systems
-
Catheter ablation reduced the number of shocks delivered to patients who have defibrillators implanted after heart attacks, concluded a study published in late last month in the "New England Journal of Medicine".
-
ATS Medical; Cambridge Heart; Coherex Medical; Escalon Medical; FlowCardia; Heartscape Technologies; InterCure; TherOx
-
St. Jude Medical (St. Paul, Minnesota) reported FDA clearance of its EnSite Fusion Registration Module, new software designed to aid in creating detailed heart models to facilitate the diagnosis and delivery of therapy for complex abnormal atrial heart rhythms, including atrial fibrillation (AF).
-
CryoCor (San Diego) reported the publication of a European study of atrial fibrillation (AF) patients treated with its Cardiac Cryoablation System to evaluate the role of atrial flutter (AFl) in the recurrence of AF and the effectiveness of an ablation strategy focused on isolating the pulmonary veins to treat the AF.
-
This remarkable study is a population analysis of a huge cohort of children in Denmark who were followed, since 1930 or later, for the presence of coronary heart disease (CHD), and had all mandatory annual examinations at schools in Copenhagen. The study analyzed data from 277,000 children, aged 7-13.
-
In this issue: Stop smoking drug Chantix rates stronger warning from FDA; Type 2 diabetes surgery on the way?; Vytorin study inconclusive; Influenza A virus found resistant to Tamiflu; FDA actions.
-
-
Refugees resettling to the united states and other developed countries frequently suffer from infectious diseases, and can pose diagnostic or therapeutic dilemmas for health care providers in their new homes.
-
Rosiglitazone (Avandia) implicated in yet another study; Prilosec and Nexium not associated with cardiac events; Anastrozole (Arimidex) shown more effective than tamoxifen for treatment of early-stage breast cancer; antibiotics show no effect on sinusitis; FDA actions.
